This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Second View: Discussing the treatment landscape and use of SGLT2 Inhibitors for the slowing of aortic stenosis.

Ticker(s): AZN, LLY, LXRX, EW, MDT, ABT

Who's the expert?

Institution: St. Louis Heart & Vascular

  • Board Certified Interventional Cardiologist

Interview Goal
This conversation will focus on the treatment landscape and us of SGLT2 inhibitors in the treatment of aortic stenosis.

Do you want answers to these questions?

Slingshot Insights Explained
Call Date
Mar 06, 2025
Call Time
03:35 PM EST
Wall Street Time

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.